Do you want to write an article for Annals? Here are our author guidelines: www.annallergy.org/content/auth...
Annals of Allergy, Asthma & Immunology
@annalsacaai.bsky.social
Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The publication is an objective evidence-based forum for the allergy/immunology specialist to keep up to date.
One institution’s experience with performing egg OIT assesses the safety and efficacy of 3 different office-based egg oral immunotherapy (OIT) protocols. Find out what they learned: www.annallergy.org/article/S108...
Comparing COVID-19-associated with AERD-associated chemosensory dysfunction (CSD), a study compares qualitative and quantitative chemosensory alterations and quality-of-life impact. Which differences between the groups were most striking? www.annallergy.org/article/S108...
Is adding dupilumab to medium-dose inhaled corticosteroids (ICS) superior to continuing high-dose ICS in patients with uncontrolled, moderate-to-severe asthma? Read more: www.annallergy.org/article/S108...
From @annalsacaai.bsky.social 🩺⬇️
Lower likelihood of #FoodAllergy resolution was associated with multiple factors, including lower income, limited health literacy, and #RacialDisparities.
This study assessed and evaluated the safety and efficacy of rapid drug desensitization for pediatric patients who had hypersensitivity reactions (HSRs) to chemotherapeutics, monoclonal antibodies, and disease-modifying antirheumatic drugs (DMARDs). Read more: www.annallergy.org/article/S108...
Building on the ORACLE studies, researchers examine the evidence supporting accessible type 2 (T2) inflammatory biomarkers—specifically blood eosinophils and fraction of exhaled nitric oxide (FeNO)—from initial diagnosis through treatment escalation. Learn more: www.annallergy.org/article/S108...
Distinguished Author Article: Precision medicine in AD strives to match defined phenotypes and molecular endotypes with the most appropriate therapy—from barrier-restoring topicals to systemic JAKis and biologics targeting IL-4, IL-13, or OX40 pathways. www.annallergy.org/article/S108...
From @annalsacaai.bsky.social 🫁
Improvements in peripheral airway reactance via #BiologicTherapy were significantly associated with clinical remission in patients with severe #asthma, indicating small airways dysfunction as a potential treatable trait in this population. #PulmSky
Food allergy affects approximately 11% of adults and 8% of children in the United States. Individuals with food allergy and caregivers of children with food allergy support reforming precautionary allergen labeling through standardized, evidence-based approaches. www.annallergy.org/article/S108...
This article reviews implementation frameworks, including system-level approaches to embedding shared decision-making into routine care, and highlights equity-informed strategies to ensure that decisions are both values aligned and realistically achievable. www.annallergy.org/article/S108...
The prevalence of eosinophilic esophagitis (EoE) has increased, and it is no longer considered a rare disease; it is also common in allergy-immunology patients. The role of the allergist in EoE is growing. Find out more: www.annallergy.org/article/S108...
Single maintenance and reliever therapy (SMART) is the guideline-recommended treatment for children with moderate to severe asthma, yet it is underutilized in pediatric practice. A new study aimed to find out why. www.annallergy.org/article/S108...
A double-blinded randomized crossover study evaluated the effects of a nasal budesonide spray on nasal cytokines, symptoms, patency, and epigenetics in patients with allergic rhinitis before and after repeated acute exposure to diesel exhaust. Find out more: www.annallergy.org/article/S108...
Do parents underestimate the emotional impact of food allergies on their older children? What is the psychosocial parental burden on families of children with food allergies? Learn more: www.annallergy.org/article/S108...
